Everyday Health on MSN
Why histological healing is the new benchmark for your ulcerative colitis
For people with UC, ‘feeling better’ is just the start. Learn why tissue-level (histological) healing is becoming the new ...
On March 18, 2026, Sandoz announced a new license, development, and commercialization partnership agreement with Samsung ...
Johnson & Johnson’s Icotyde receives US FDA approval for first-line systemic treatment of plaque psoriasis with a targeted oral peptide: Spring House, Pennsylvania Friday, March ...
Shares of Protagonist Therapeutics PTGX have gained nearly 7% over the past week. The upside came after the company announced ...
Evommune’s role within the NYSE Composite highlights biotechnology research, clinical stage development, financial ...
Explore Eli Lilly and Company stock: obesity drug tirzepatide sales +115%, new retatrutide diabetes data, and Kisunla ...
Pharmaceutical Technology on MSN
J&J wins FDA approval for Icotyde to enter psoriasis pill market
J&J’s Icotyde will take on AbbVie’s blockbuster injectable Skyrizi as analysts forecast a blockbuster future for the pill.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results